AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Get Alerts ABBV Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.8%
EPS Growth %: +107.5%
Join SI Premium – FREE
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media:
| Investors:
|
View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-morgan-stanley-24th-annual-global-healthcare-conference-302868211.html
SOURCE AbbVie
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Webull Enters Next Phase of Growth in Thailand Following Pi Securities Acquisition, Targets THB 200 Billion in AUM
- Peerless Opulence Arrives in Scottsdale: The 2026 Mercedes-Maybach GLS 600 4MATIC® SUV
- The Inner Circle acknowledges Michelle Bishop as a Pinnacle Professional Member Inner Circle of Excellence
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share